iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001808865

SEC filings (opens in a new tab)

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding iTeos Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of ITOS: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	139	2	151	+14
Shares	36.2M	3.73M	36.6M	+4.14M (+12.8%)
Value	$536.8M	$55.4M	$373.3M	−$108.1M (−22.5%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held iTeos Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to ITOS in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	3,882,549	$39.6M	0.00%
Tang Capital Management LLC	2,407,800	$24.6M	1.76%
Cubist Systematic Strategies, LLC	132,364	$1.35M	0.02%
Schonfeld Strategic Advisors LLC	68,243	$696.8K	0.01%
HRT Financial LP	58,450	$596.0K	0.00%
Lazard Asset Management LLC	57,743	$589.0K	0.00%
Trexquant Investment LP	49,006	$500.4K	0.01%
Stonepine Capital Management, LLC	30,000	$306.3K	0.19%
Gsa Capital Partners LLP	25,787	$263.0K	0.02%
Massachusetts Financial Services Co	23,662	$241.6K	0.00%
Man Group plc	21,653	$221.1K	0.00%
Corton Capital Inc.	20,332	$207.6K	0.10%
XTX Topco Ltd	18,207	$185.9K	0.01%
Acadian Asset Management LLC	16,901	$172.0K	0.00%
Intech Investment Management LLC	15,085	$154.0K	0.00%
Prelude Capital Management, LLC	13,877	$141.7K	0.01%
SG Americas Securities, LLC	12,358	$126.0K	0.00%
Tudor Investment Corp Et Al	11,649	$118.9K	0.00%
Virtu Financial LLC	10,033	$102.0K	0.01%
State of Wyoming	3,320	$33.9K	0.00%
Point72 (DIFC) Ltd	2,999	$30.6K	0.00%
Aquatic Capital Management LLC	1,500	$15.3K	0.00%
Harbor Capital Advisors, Inc.	328	$3.00K	0.00%
Ronald Blue Trust, Inc.	116	$1.72K	0.00%
Sterling Capital Management LLC	91	$929	0.00%
Capital Performance Advisors LLP	30	$306	0.00%

Sold out (12)

Institutions that held iTeos Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of ITOS in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Deerfield Management Company, L.P. (Series C)	723,000	$10.7M
ExodusPoint Capital Management, LP	37,673	$559.0K
Catalyst Funds Management Pty Ltd	29,000	$430.4K
Los Angeles Capital Management LLC	25,398	$376.9K
Group One Trading, L.P.	23,439	$347.8K
Y-Intercept (Hong Kong) Ltd	20,814	$308.9K
Caption Management, LLC	19,000	$282.0K
Bank of Montreal	16,485	$249.3K
Simplex Trading, LLC	16,083	$238.0K
Cornercap Investment Counsel Inc	13,119	$194.7K
Allspring Global Investments Holdings, LLC	3,776	$56.0K
Pacer Advisors, Inc.	205	$3.04K

Not filed for Q3 2024 yet (2)

Institutions that held iTeos Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ITOS in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	3,731,036	$55.4M
Sofos Investments, Inc.	0	$148